// App-Quantinova.ai

424 : Single arm phase II study of docetaxel and lapatinib in metastatic urothelial cancer: USC trial 4B-10-4.

Researchers

Presenter

  • Sujie Tang

Principal Investigators

  • Tanya B. Dorff

  • Denice D Tsao-Wei

  • Kristy Massopust

  • Charlean Ketchens

  • James Hu

  • Amir Goldkorn

  • Sarmad Sadeghi

  • Jacek K. Pinski

  • Monica Averia

  • Susan G. Groshen

  • Michael F. Press

  • Anne K. Schuckman

  • David I. Quinn

Medical Centers

  • Comprehensive Blood and Cancer Center, Bakersfield, CA

  • USC Norris Comprehensive Cancer Center, Los Angeles, CA

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

  • University of Southern California, Los Angeles, CA

  • University of Southern California, Institute of Urology, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Advanced Urothelial Carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • Lapatinib

Outcome

  • N/A

Study Design

  • Single Arm

  • Simon'S Two Stage Design

Phase

  • II

Study Id's

  • NCT01382706

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved